Last updated: August 9, 2021
Sponsor: Seoul National University Bundang Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stomach Cancer
Gastric Cancer
Digestive System Neoplasms
Treatment
N/AClinical Study ID
NCT03079596
B-1608-357-006
Ages 20-68 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Elective surgery
- American Society of Anesthesiologists (ASA) scores < 3
- Gastric cancer, adenocarcinoma, possible to perform laparoscopic total gastrectomy andproximal gastrectomy
- Informed consent
- No other treatment (Radiation, Chemotherapy or Immunotherapy) on this gastric canceror other type of cancer.
- No systemic inflammatory disease
Exclusion
Exclusion Criteria:
- conversion to open
Study Design
Total Participants: 100
Study Start date:
October 01, 2019
Estimated Completion Date:
December 31, 2022
Study Description
Connect with a study center
Seoul National University Bundang Hospital
Seongnam, Gyeonggi 463-707
Korea, Republic ofActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.